Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
REPL on Nasdaq
Christopher Sarchi - trading volume in the past year for Replimune Group, Inc.
Holdings reported by Christopher Sarchi for Replimune Group, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
132K |
$1.64M |
$12.42 |
Apr 1, 2025 |
Direct |
|
|
| Employee Stock Option (right to buy) |
67.5K |
|
|
Apr 1, 2025 |
Direct |
Common Stock |
|
| Employee Stock Option (right to buy) |
66.7K |
|
|
Apr 1, 2024 |
Direct |
Common Stock |
|
Transactions reported by Christopher Sarchi for Replimune Group, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.